Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype
- 1 August 1991
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 64 (2) , 267-273
- https://doi.org/10.1038/bjc.1991.290
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Microtubule-associated protein-2 stimulates DNA synthesis catalyzed by the nuclear matrixBiochemical and Biophysical Research Communications, 1989
- Nuclear protein matrix as a target for estramustine‐induced cell deathThe Prostate, 1986
- Spindle disturbances in mammalian cells. I. changes in the quantity of free sulfhydryl groups in relation to survival and c-mitosis in V79 chinese hamster cells after treatment with colcemid, diamide, carbaryl and methyl mercuryChemico-Biological Interactions, 1983
- Plasma Concentrations of Estramustine Phosphate and Its Major Metabolites in Patients with Prostatic Carcinoma Treated with Different Doses of Estramustine Phosphate (Estracyt®).Scandinavian Journal of Urology and Nephrology, 1981
- Mechanism of action of cytochalasin B on actinCell, 1980
- Estramustine Phosphate in the Treatment of Advanced Prostatic CancerBritish Journal of Urology, 1980
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)Scandinavian Journal of Urology and Nephrology, 1977
- Further evidence of the similarity of microtubule protein from mitotic apparatus and sperm tail of the sea urchin, as a substrate in thiol-disulfide exchange reactionExperimental Cell Research, 1973
- Vinblastine and microtubules: I. Induction and isolation of crystals from sea urchin oocytesExperimental Cell Research, 1971